Does EVOLOCUMAB Cause Acute myocardial infarction? 113 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 113 reports of Acute myocardial infarction have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.1% of all adverse event reports for EVOLOCUMAB.
113
Reports of Acute myocardial infarction with EVOLOCUMAB
0.1%
of all EVOLOCUMAB reports
13
Deaths
73
Hospitalizations
How Dangerous Is Acute myocardial infarction From EVOLOCUMAB?
Of the 113 reports, 13 (11.5%) resulted in death, 73 (64.6%) required hospitalization, and 12 (10.6%) were considered life-threatening.
Is Acute myocardial infarction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 113 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Acute myocardial infarction?
ROSIGLITAZONE (2,437)
TESTOSTERONE (871)
ASPIRIN (826)
CLOPIDOGREL BISULFATE (624)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (521)
TICAGRELOR (442)
RIVAROXABAN (375)
METFORMIN (370)
LENALIDOMIDE (354)
METFORMIN\ROSIGLITAZONE (351)
Which EVOLOCUMAB Alternatives Have Lower Acute myocardial infarction Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE